Tenaya Therapeutics, Inc. TNYA
Set alert
0.37 USD +0.01 +3.66%
As of Nov 3, 10:00 AM ET
0.351 Day range 0.3749
0.361 52-week range 1.54
- YTD
- -47.44%
- 1 year
- -73.83%
- Open
- 0.3578
- Prev close
- 0.361
- Mkt cap
- 85.45M
- Vol
- 355.01K
- Avg vol
- 2.78M
- EPS
- -0.52
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.351
- High
- 0.3749
- Forward P/E
- -1.28
- Beta
- 2.35
- Short ratio
- 2.31
- Inst. own
- 73.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.40
- 200-d avg
- 3.26
- 1y target
- 18.50
MAX chart
Events in this range
- Mar 18, 2024Earnings: -0.4; estimate -0.45; surprise 11.11%
- May 14, 2024Earnings: —; estimate -0.43; surprise —%
- May 14, 2024Earnings: -0.4; estimate -0.43; surprise 6.98%
- Aug 8, 2024Earnings: —; estimate -0.4; surprise —%
- Aug 8, 2024Earnings: -0.34; estimate -0.4; surprise 15%
- Oct 18, 2024Rating: Canaccord Genuity · Buy → Buy
- Nov 6, 2024Earnings: -0.3; estimate -0.37; surprise 18.92%
- Nov 7, 2024Rating: Chardan Capital · Buy → Buy
- Nov 25, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 26, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 18, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 18, 2024Rating: Chardan Capital · Buy → Buy
Signals (74)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Dec 8, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| RSI: Overbought | Oct 6, 2025 | 1 year ago |
Newest 20 of 74.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 18.50 +4843.9% upside
Now 0.3742
- Target (low)
- 6.00
- Target (mean)
- 18.50
- Target (high)
- 40.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
- Strong buy3
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 9
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.315 | -0.35 – -0.28 | -0.40 | +21.3% | 0 | 0.0% | 8 |
| Next quarter | -0.33 | -0.36 – -0.30 | -0.40 | +17.5% | 0 | 0.0% | 3 |
| Current year | -1.33 | -1.39 – -1.11 | -1.68 | +21.1% | 0 | 0.0% | 8 |
| Next year | -1.26 | -1.42 – -0.91 | -1.33 | +5.2% | 3.29M | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Dec 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 7, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 18, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 10, 2024 | William Blair | Initiated | — | Outperform |
| May 16, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 21, 2024 | Chardan Capital | Reiterated | Buy | Buy |
| Mar 20, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 30, 2023 | Leerink Partners | Initiated | — | Outperform |
| Oct 9, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| Aug 11, 2023 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 10, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 10, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 12, 2023 | Chardan Capital | Maintained | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 9, 2023 | Chardan Capital | Maintained | — | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Jan 24, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Nov 11, 2022 | Chardan Capital | Maintained | — | Buy |
| Nov 8, 2022 | Canaccord Genuity | Initiated | — | Buy |
| Aug 11, 2022 | Chardan Capital | Maintained | — | Buy |
| Jun 15, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| May 17, 2022 | Morgan Stanley | Maintained | — | Overweight |